Unlocking RNA drug discovery with AI
About Atomic AI
Atomic AI is developing the cutting-edge fusion of machine learning and structural biology to unlock RNA drug discovery.
The technology holds the potential to discover novel structure targets across the transcriptome and for the design of RNA-targeted small molecules, RNA-based medicines and RNA tools.
The company’s cross-functional team of AI researchers and structural biologists is moving quickly to build the world’s largest database of RNA structures, locate druggable targets within them, and design new RNA-based therapeutics.
Disclaimer: Atomic AI doesn't use GPT-3